​

Traws Pharma (TRAW) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Traws Pharma Revenue Highlights

Latest Revenue (Y)

$226.00K

0

Traws Pharma Revenue by Period

Traws Pharma Revenue by Year

DateRevenueChange
2023-12-31$226.00K-
2022-12-31$226.00K-
2021-12-31$226.00K-2.16%
2020-12-31$231.00K-89.42%
2019-12-31$2.18M-

Traws Pharma generated $226.00K in revenue during NA 2023, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Traws Pharma Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$2.73M4694.74%
2025-03-31$57.00K1.79%
2024-12-31$56.00K-1.75%
2024-09-30$57.00K-
2024-06-30$57.00K1.79%
2024-03-31$56.00K-
2023-12-31$56.00K-1.75%
2023-09-30$57.00K-
2023-06-30$57.00K1.79%
2023-03-31$56.00K-
2022-12-31$56.00K-1.75%
2022-09-30$57.00K-
2022-06-30$57.00K1.79%
2022-03-31$56.00K-
2021-12-31$56.00K-1.75%
2021-09-30$57.00K-
2021-06-30$57.00K1.79%
2021-03-31$56.00K-1.75%
2020-12-31$57.00K-13.64%
2020-09-30$66.00K17.86%
2020-06-30$56.00K7.69%
2020-03-31$52.00K73.33%
2019-12-31$30.00K-52.38%
2019-09-30$63.00K-96.88%
2019-06-30$2.02M2873.53%
2019-03-31$68.00K15.25%
2018-12-31$59.00K-50.83%
2018-09-30$120.00K-75.26%
2018-06-30$485.00K-

Traws Pharma generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Traws Pharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BOLTBolt Biotherapeutics$7.69M$2.17M
EVGNEvogene$5.64M$4.19M
IMRNImmuron$1.80M$2.36M
BRTXBioRestorative Therapies$401.00K$11.80K
TRAWTraws Pharma$226.00K-
DWTXDogwood Therapeutics--
IMNNImunon--
COCPCocrystal Pharma--
CINGCingulate--
SNSESensei Biotherapeutics--
MBIOMustang Bio--

TRAW Revenue FAQ

What is Traws Pharma’s yearly revenue?

Traws Pharma's yearly revenue for 2023 was $226K, representing an increase of 0% compared to 2022. The company's yearly revenue for 2022 was $226K, representing an increase of 0% compared to 2021. TRAW's yearly revenue for 2021 was $226K, representing a decrease of -2.16% compared to 2020.

What is Traws Pharma’s quarterly revenue?

Traws Pharma's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.73M, a 4694.74% increase from the previous quarter (Q1 2025), and a 4694.74% increase year-over-year (Q2 2024). TRAW's quarterly revenue for Q1 2025 was $57K, a 1.79% increase from the previous quarter (Q4 2024), and a 1.79% increase year-over-year (Q1 2024).

What is Traws Pharma’s revenue growth rate?

Traws Pharma's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -89.65%.